News and Trends 22 Sep 2022 Rivus Pharmaceuticals raises $132M for treatment of obesity and cardio-metabolic disorders …markers. Both phase 1 and 2a metabolic data showed that HU6 was well tolerated across all dose levels with no serious adverse events (SAEs) or deaths reported. Rivus Pharmaceuticals recently… September 22, 2022 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 11 Oct 2022 Clinical Microbiomics expanding with €10M million investment …– the microbiome. We challenge the idea that the complexity of the microbiome prevents us from exploring its potential to tackle the most pressing health questions of our time. “Seventure… October 11, 2022 - 2 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
Best in Biotech 14 Jan 2025 Singapore’s biotech scene: 7 companies leading the way in 2025 …treatment-related adverse events. The company also entered into a clinical trial collaboration and supply agreement with Merck in May 2023 to evaluate HMBD-001 in combination with Merck’s cetuximab in squamous… January 14, 2025 - 11 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 11 Jan 2023 AstraZeneca’s Airsupra gets US approval as new rescue treatment for asthma …most common adverse events including headache, oral candidiasis, cough and dysphonia. Co-development The co-development partnership between AstraZeneca and Avillion has recently expanded to include the BATURA study, a randomized phase… January 11, 2023 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
In Depth 14 May 2025 The stem cell race for Parkinson’s disease: Recent studies show significant promise …there were no reports of severe adverse reactions, although there were some mild to moderate events such as itching at the injection site and an instance of transient dyskinesia, a… May 14, 2025 - 8 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 10 Mar 2022 Emerging Startups Take Aim at Lysosomal Storage Disorders …is miglustat, a drug that prevents the harmful buildup of toxic chemicals that lead to symptoms of NPC. However, no current treatments can tackle the underlying cause of the disease…. March 10, 2022 - 4 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 7 Feb 2023 Antibody candidate for treating serious liver disease …Biochemistry and Biophysics, Karolinska Institutet. “Our results show that the pharmacological blocking of the VEGB-B signal pathway in mice prevents the accumulation of fat in the liver and reduces the… February 7, 2023 - 4 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 20 May 2022 Zealand Pharma’s drug for rare metabolic disease smashes phase III …suffering from more than three hypoglycemic events per week despite being heavily treated. Adding dasiglucagon to the standard of care didn’t show any significant benefits over regular treatment when the… May 20, 2022 - 4 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
Best in Biotech 30 Mar 2020 10 Unusual Applications of CRISPR Gene Editing …The tool acts as a recorder of events in the lifetime of a cell, such as exposure to antibiotics, nutrients, viruses and light. To achieve this, CRISPR was programmed into… March 30, 2020 - 8 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
In Depth 4 Jun 2019 Ultra-Fast Diagnostics Could Transform Sexual Health …some of the shame and embarrassment that prevents many people from going to get tested. Selfdiagnostics uses a much faster form of PCR to test for chlamydia and gonorrhea, which… June 4, 2019 - 7 minutesmins - By David Cox Share WhatsApp Twitter Linkedin Email
News and Trends 13 Apr 2017 Coming from Behind: How Italy is Revamping its Biotech Industry …their tech transfer offices, monitoring their activity and objectives and aligning them with international standards. New events and accelerator programs, like BioInItaly, Meet in Italy for Life Sciences and Bioupper,… April 13, 2017 - 5 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
Inside Labiotech 6 Dec 2018 We Are Now More Than 150,000 Awesome Biotechers Every Month …But that doesn’t mean we’re stopping here! We’re continuing our globe-trotting with our Refresh events, looking into ways to help you find a biotech job, and finding fun ways to… December 6, 2018 - 2 minutesmins - By Editorial Team Share WhatsApp Twitter Linkedin Email